Patents Assigned to Genetics Indtitute LLC
  • Use of interleukin-11 to prevent immune-mediated cytotoxicity
    Patent number: 6953777
    Abstract: The use of interleukin-11 to prevent, to ameliorate, and to treat an immune-mediated disease in a mammal in need of such treatment is disclosed.
    Type: Grant
    Filed: March 9, 2000
    Date of Patent: October 11, 2005
    Assignees: Genetics Indtitute LLC, Yale University
    Inventors: James Keith, Joseph M. Carroll, Jordan S. Pober